Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.050
-0.080 (-1.94%)
At close: Aug 13, 2025, 4:00 PM
4.000
-0.050 (-1.23%)
Pre-market: Aug 14, 2025, 9:11 AM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $859.18 million as of August 14, 2025. Its market cap has increased by 224.83% in one year.
Market Cap
859.18M
Enterprise Value
789.95M
1-Year Change
224.83%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $859.18M, a decrease of -62.46%. That is a compound annual growth rate of -21.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 859.18M | 284.98% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |